PRIA Logo™
New JerseyA913220th Legislature (2024-2025)HouseWALLET

Authorizes medical cannabis for treatment of sickle cell anemia.

Sponsored By: Atkins, Reginald W., Angela V. McKnight (Democratic), Verlina Reynolds-Jackson (Democratic), William W. Spearman (Democratic), Shirley K. Turner (Democratic)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Sickle cell patients gain medical cannabis access

Beginning January 12, 2026, sickle cell anemia qualifies for New Jersey’s medical cannabis program. Patients must be New Jersey residents and have a health care practitioner authorize medical cannabis use. The law expands treatment access but does not set a financial benefit or payment amount.

Sponsors & Cosponsors

Sponsors

  • Atkins, Reginald W.

    Affiliation unavailable

  • Angela V. McKnight

    Democratic • Senate

  • Verlina Reynolds-Jackson

    Democratic • House

  • William W. Spearman

    Democratic • House

  • Shirley K. Turner

    Democratic • Senate

Cosponsors

  • Linda S. Carter

    Democratic • House

  • Joe Danielsen

    Democratic • House

  • Hall, Garnet R.

    Affiliation unavailable

  • William B. Sampson IV

    Democratic • House

  • Shanique Speight

    Democratic • House

  • Benjie E. Wimberly

    Democratic • Senate

Roll Call Votes

All Roll Calls

Yes: 108 • No: 2

Senate vote • 12/22/2025

3RDG FINAL PASSAGE

Yes: 37 • No: 0

House vote • 5/22/2025

3RDG FINAL PASSAGE

Yes: 71 • No: 2 • Other: 4

Actions Timeline

  1. Approved by Governor — P.L.2025, c.223.

    1/12/2026Governor

  2. Passed Senate, PBH — (37-0)

    12/22/2025Senate

  3. Substituted for S2392

    12/22/2025Senate

  4. Reported, 2nd Reading in Senate

    12/15/2025Senate

  5. Referred to Senate Budget and Appropriations Committee

    12/11/2025Senate

  6. Reported, 2nd Reading in Senate

    11/13/2025Senate

  7. Received in Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

    5/29/2025Senate

  8. Passed Assembly — (71-2-4)

    5/22/2025House

  9. Reported, 2nd Reading in Assembly

    3/20/2025House

  10. Reported, Referred to Assembly Appropriations Committee

    3/6/2025House

  11. Introduced, 1st Reading in Assembly, Referred to Assembly Health Committee

    1/9/2024House

Bill Text

  • Version PL2025

    3/30/2026

    HTMLPDF

  • Version AL2025

    3/20/2026

    HTMLPDF

  • Assembly Health (3/6/25 TR)

    12/22/2025

    HTMLPDF

  • 12/18/25; CC

    12/18/2025

    HTMLPDF

  • Senate Budget and Appropriations Substitute (12/15/25)

    12/16/2025

    HTMLPDF

  • Senate Health, Human Services and Senior Citizens Substitute (11/13/25)

    11/14/2025

    HTMLPDF

  • Assembly Appropriations Substitute (3/20/25)

    3/21/2025

    HTMLPDF

  • 3/20/25; as introduced

    3/20/2025

    HTMLPDF

  • Assembly Health Substitute (3/6/25)

    3/7/2025

    HTMLPDF

  • As Introduced

    3/4/2025

    HTMLPDF

Related Bills

Back to State Legislation